The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: acyclovir     Quarter: 2016Q3

Total Drug/Injury Combinations: 227     Number of Pages: 12

DRUGNAME PT EventCount
ACYCLOVIR. Blood alkaline phosphatase increased 1 view events
ACYCLOVIR. Blood creatinine increased 1 view events
ACYCLOVIR. Blood pressure decreased 1 view events
ACYCLOVIR. Blood pressure increased 1 view events
ACYCLOVIR. Blood thyroid stimulating hormone decreased 1 view events
ACYCLOVIR. Bradycardia 1 view events
ACYCLOVIR. Cardiac arrest 1 view events
ACYCLOVIR. Cardiac tamponade 1 view events
ACYCLOVIR. Cataract 1 view events
ACYCLOVIR. Chemical burn of skin 1 view events
ACYCLOVIR. Coarctation of the aorta 1 view events
ACYCLOVIR. Cyanosis neonatal 1 view events
ACYCLOVIR. Cystitis haemorrhagic 1 view events
ACYCLOVIR. Cytomegalovirus infection 1 view events
ACYCLOVIR. Cytomegalovirus viraemia 1 view events
ACYCLOVIR. Death 1 view events
ACYCLOVIR. Delirium 1 view events
ACYCLOVIR. Delusion 1 view events
ACYCLOVIR. Diastolic dysfunction 1 view events
ACYCLOVIR. Disseminated intravascular coagulation 1 view events

Total Drug/Injury Combinations: 227     Number of Pages: 12

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)